Prospective study of progeny of inapparent equine carriers of equine infectious anemia virus.

This research study investigates the progeny of horses carrying the equine infectious anemia (EIA) virus. The research found significant differences in infection rates between adult sentinel horses and foals, possibly due to the protective value of colostral immunity and differences in attraction to blood-feeding vectors.

Study Background and Methodology

• The research conducted was a prospective study spanning over a duration of 4 years. It focused on the offspring (progeny) of a horse group that tested positive for the equine infectious ania (EIA) antibody through the agar-gel immunodiffusion (AGID) test.
• Alongside the EIA-positive mares and their foals, sentinel horses – horses with a negative AGID test – were included in the study. The sentinels were allowed to interact freely with the infected mares and their foals, simulating a natural pasture environment.
• This was all conducted within a region with a high population of potential vectors – organisms that can transmit infectious diseases.

Findings and Observations

• Out of 27 adult sentinel horses, 8 (approximately 30%) demonstrated seroconversion – the development of specific antibodies in response to an infection – at annual rates varying from 0% to 75%.
• Comparatively, only 2 out of 31 (approximately 6%) weaned foals became infected.
• The researchers found a significant difference (P less than 0.05) between the adult sentinel horses’ seroconversion rates and the infection rate of foals.

Possible Explanations and Implications

• The study suggests possible explanations for the difference in infection rates. One of these is the protective value of colostral immunity – the immunity provided to newborns through the mother’s first milk (colostrum).
• Another potential factor could be the differences in attractiveness to blood-feeding vectors between adults and foals.
• The researchers found that the detectable colostral immunity to the EIA virus as revealed in the AGID test could persist from between 25 to 195 days, averaging around 124 days.
• This study’s findings could hold potential value for understanding and managing equine infectious anemia and similar diseases, particularly in regions with high vector populations.